These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29770901)

  • 41. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
    Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.
    Avedissian SN; Pais GM; O'Donnell JN; Lodise TP; Liu J; Prozialeck WC; Joshi MD; Lamar PC; Becher L; Gulati A; Hope W; Scheetz MH
    J Antimicrob Chemother; 2019 Aug; 74(8):2326-2334. PubMed ID: 31065686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Importance of vancomycin loading doses in intermittent infusion regimens.
    Šíma M; Hartinger J; Cikánková T; Slanař O
    J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a sparse sampling strategy for determining vancomycin pharmacokinetics in preterm neonates: application of optimal sampling theory.
    Burstein AH; Gal P; Forrest A
    Ann Pharmacother; 1997 Sep; 31(9):980-3. PubMed ID: 9296235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent.
    Parker SL; Guerra Valero YC; Ordóñez Mejia JL; Roger C; Lipman J; Roberts JA; Wallis SC
    Bioanalysis; 2017 Jun; 9(12):911-924. PubMed ID: 28617036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets.
    Gomez DS; Campos EV; de Azevedo RP; Silva JM; Ferreira MC; Sanches-Giraud C; Silva CV; Santos SR
    Burns; 2013 May; 39(3):445-50. PubMed ID: 22867735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trough concentrations of vancomycin: adult therapeutic targets are not appropriate for children.
    Gordon CL; Thompson C; Carapetis JR; Turnidge J; Kilburn C; Currie BJ
    Pediatr Infect Dis J; 2012 Dec; 31(12):1269-71. PubMed ID: 22828642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.
    Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
    Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.
    Rodvold KA; Everett JA; Pryka RD; Kraus DM
    Clin Pharmacokinet; 1997 Jul; 33(1):32-51. PubMed ID: 9250422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
    Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A
    Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and efficacy of ropivacaine for continuous epidural infusion in neonates and infants.
    Bösenberg AT; Thomas J; Cronje L; Lopez T; Crean PM; Gustafsson U; Huledal G; Larsson LE
    Paediatr Anaesth; 2005 Sep; 15(9):739-49. PubMed ID: 16101704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation.
    Buck ML
    Pharmacotherapy; 1998; 18(5):1082-6. PubMed ID: 9758319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.
    Rapp HJ; Molnár V; Austin S; Krohn S; Gädeke V; Motsch J; Boos K; Williams DG; Gustafsson U; Huledal G; Larsson LE
    Paediatr Anaesth; 2004 Sep; 14(9):724-32. PubMed ID: 15330953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal vancomycin continuous infusion: still a confusion?
    Gwee A; Cranswick N; Metz D; Coghlan B; Daley AJ; Bryant PA; Curtis N
    Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.